Goldman Sachs
VIVS

Goldman Sachs’s VivoSim Labs VIVS Stock Holding History

Goldman Sachs’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,072
Closed -$23K – 7150
2026
Q1 		$23K Buy
+16,072
New +$31.5K ﹤0.01% 6353
2021
Q2 		– Sell
-1,438
Closed -$166K – 6574
2021
Q1 		$166K Buy
+1,438
New +$225K ﹤0.01% 5704
2019
Q3 		– Sell
-1,803
Closed -$226K – 5420
2019
Q2 		$226K Buy
1,803
+1,695
+1,569% +$320K ﹤0.01% 4739
2019
Q1 		$25K Buy
108
+12
+13% +$3.02K ﹤0.01% 5039
2018
Q4 		$22K Sell
96
-165
-63% -$41.6K ﹤0.01% 5149
2018
Q3 		$72K Buy
261
+50
+24% +$15K ﹤0.01% 5222
2018
Q2 		$71K Sell
211
-609
-74% -$201K ﹤0.01% 5285
2018
Q1 		$202K Buy
820
+63
+8% +$18.4K ﹤0.01% 4999
2017
Q4 		$243K Sell
757
-111
-13% -$41.3K ﹤0.01% 5308
2017
Q3 		$462K Buy
868
+556
+178% +$296K ﹤0.01% 5149
2017
Q2 		$197K Sell
312
-83
-21% -$55.8K ﹤0.01% 5808
2017
Q1 		$301K Sell
395
-12
-3% -$9.51K ﹤0.01% 5462
2016
Q4 		$331K Buy
407
+293
+257% +$233K ﹤0.01% 5404
2016
Q3 		$104K Buy
114
+50
+78% +$49K ﹤0.01% 6212
2016
Q2 		$58K Sell
64
-184
-74% -$123K ﹤0.01% 6376
2016
Q1 		$129K Sell
248
-1,568
-86% -$797K ﹤0.01% 5932
2015
Q4 		$1.08M Sell
1,816
-2,883
-61% -$2.09M ﹤0.01% 4220
2015
Q3 		$3.02M Buy
4,699
+1,364
+41% +$1.04M ﹤0.01% 3369
2015
Q2 		$3.02M Buy
3,335
+258
+8% +$289K ﹤0.01% 3428
2015
Q1 		$2.62M Buy
3,077
+698
+29% +$964K ﹤0.01% 3516
2014
Q4 		$4.14M Buy
2,379
+825
+53% +$1.27M ﹤0.01% 3176
2014
Q3 		$2.38M Sell
1,554
-1,622
-51% -$2.94M ﹤0.01% 3767
2014
Q2 		$6.36M Buy
3,176
+1,620
+104% +$2.72M ﹤0.01% 2763
2014
Q1 		$2.85M Buy
1,556
+1,466
+1,629% +$3.4M ﹤0.01% 3627
2013
Q4 		$239K Sell
90
-48
-35% -$94.2K ﹤0.01% 5849
2013
Q3 		$191K Buy
+138
New +$193K ﹤0.01% 5902

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

Goldman Sachs's VIVS Position: Q2 2026 in Review

Goldman Sachs sold out of VivoSim Labs (VIVS) in Q2 2026, closing a stake of 16,072 shares — an estimated $23K sold.

Goldman Sachs first reported a position in VIVS in Q3 2013 and held it in 26 quarters. The position peaked at $6.36M in Q2 2014. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • Goldman Sachs reported no remaining VivoSim Labs position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 16,072 VivoSim Labs shares in Q2 2026, an estimated $23K.
  • Goldman Sachs first reported a position in VivoSim Labs in Q3 2013 and held it in 26 quarters.
  • Goldman Sachs's VivoSim Labs position peaked at $6.36M in Q2 2014.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.